Tag Archives: Pfizer-BioNTech

The US Food and Drug Administration on Monday gave the green light to updated Covid-19 vaccine booster shots from Moderna and Pfizer/BioNTech. The updated vaccines are each approved for people 12 and older and are authorized under emergency use for individuals 6 months through 11 years old. As part of …

‘Expected side effects were in-keeping with what can be anticipated from the vaccine in this age group,’ regulator says Britain’s health regulator on Tuesday authorized the use of a Pfizer/BioNTech coronavirus vaccine for infants and children aged six months to 4 years. In a statement, the Medicines and Healthcare products …

Pfizer Inc and BioNTech said on Thursday they had asked US regulators to approve emergency use of their COVID-19 vaccine for children aged from five to 11, Pfizer said in a post on Twitter. “We and BioNTech Group officially submitted our request to US FDA for Emergency Use Authorization (EUA) …

Moderna Inc.‘s COVID-19 vaccine generated more than double the antibodies of a similar shot made by Pfizer Inc. and BioNTech SE in research directly comparing immune responses to the inoculations. A study of almost 2,500 workers at a major Belgium hospital system found antibody levels among individuals who hadn’t been …

New Zealand reported its first recorded death linked to the Pfizer/BioNTech COVID-19 vaccine, the health ministry said on Monday after a woman suffered a rare heart muscle inflammation side effect. The report comes as the country battles an outbreak of the Delta variant of the coronavirus after nearly six months …

While the world is unlikely to exit the COVID-19 pandemic any time soon, vaccines have given hope and freedom to millions around the world who have lived under tight restrictions for over 18 months. In the wake of their creation and approval by the relevant medical authorities, the roll-out of …

Cape Town-based company Biovac expected to produce 100 million doses annually, destined for African Union countries, under the deal. Pfizer and BioNTech have said they struck a deal with South Africa-based company Biovac for the production of COVID-19 vaccines for the African Union (AU). In a statement published on Wednesday, …

Sanofi-GSK hopes to get approvals by the end of this year after early-stage results showed the vaccine produces a robust immune response. Europe’s drug regulator said on Tuesday it had started a real-time review of the COVID-19 vaccine developed by French drugmaker Sanofi and the UK’s GlaxoSmithKline, the fifth shot …

Authorities are trying to increase the speed and effectiveness of vaccinations as the highly infectious Delta variant spreads. Germany is recommending that all people who get a first shot of the AstraZeneca coronavirus vaccine switch to a different type of vaccine for their second shot. The aim is to increase …

Countries should also avoid giving the Astrazeneca coronavirus vaccine to people over 60, the head of the EU drug regulator’s COVID-19 task force was quoted on Sunday as saying, amid fears over rare blood clotting and as more vaccines become available. The European Medicines Agency (EMA) considers the Astrazeneca shot …

Pfizer Inc said on Tuesday it will begin testing its COVID-19 vaccine in a bigger group of children under age 12 after selecting a lower dose of the shot in an earlier stage of the trial. The study will enroll up to 4,500 children at more than 90 clinical sites …

The EU has concluded a deal with Pfizer-BioNTech for up to 1.8 billion extra doses of its Covid-19 vaccine, according to European Commission chief Ursula von der Leyen. “Happy to announce that the EU Commission has just approved a contract for guaranteed 900 million doses (+900 million options) with Pfizer-BioNTech …